IDFC First Bank Gets 'Buy' Upgrade From ICICI Securities — Capital Infusion, Fair Valuations To Aid Re-Rating

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

We upgrade IDFC First Bank Ltd. to Buy with a revised target price of Rs 75, as the large proposed capital infusion (Rs 75 billion) improves visibility on superior loan growth/operating leverage (without any material dilution in book value) topped with inexpensive valuations.

The announced preferential infusion to Warburg and ADIA should boost the bank’s CET1 by ~280bps, catapulting its pro forma CET1 to ~16.5%. With a meaty share of fixed rate loans, at 60–65% of overall, ~32% share of wholesale TD/borrowings and an additional ~30% share of high-rate savings in overall funding, IDFC First Bank seems well placed on NIM and could surprise positively.

MFI slippages have been elevated and could rise further in the near term, but the share itself is receding (now down to 4.8% versus 7.2% YoY). Ex-MFI, gross slippages have been stable (though elevated) and are a key monitorable; but improved disclosures and contained SMA figures along with an improving overall asset quality environment provide reasonable comfort.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.